ndd Medical Technologies Introduces EasyOne Air for Fast and Accurate Spirometry Testing

Lucida Medical (Cambridge University Spin-out) Joins GE Healthcare Edison™ Accelerator Programme

Lucida Medical was invited to join the Edison Accelerator programme for its pioneering work in helping identify prostate cancer and its exceptional development team led by Prof Evis Sala and Dr Antony Rix, both highly experienced in artificial intelligence, or AI, medical technology.

Boston Scientific Exercises Option to Acquire Farapulse, Inc.

FARAPULSE Pulsed Field Ablation (PFA) System is a non-thermal ablation system for the treatment of atrial fibrillation (AF) and other cardiac arrhythmias.  

ndd Medical Technologies, Inc., (lung function testing), today announced the availability of EasyOne Air, a new, all-in-one spirometry solution designed for primary care physicians. The portable and connected device requires no calibration, warm-up time or maintenance and provides clinicians with a simple and proven method of lung function testing. EasyOne Air’s intuitive, full-color touch screen display also ensures accurate and immediate results through real-time curves and parameters.

Lance Anderson, Vice President of Palmer Associates and National Institute for Occupational Safety and Health (NIOSH) approved course instructor said, “I’ve used ndd products for many years because of the durability and accuracy of the devices.” He added, “The large, easy-to-read screen on the EasyOne Air makes interacting with the device very simple and the results print-outs are so concise and easy to understand that I find my students naturally gravitating to these devices.”

Every four minutes, a person dies from chronic obstructive pulmonary disease (COPD)1, the third leading cause of death in the U.S.2 With millions of people already diagnosed, an additional 12 million Americans may have the disease without knowing it3. Early diagnosis, along with ongoing treatment and monitoring, can slow the progression of lung disease and have a significant impact on the quality of a patient’s life. By moving lung function testing beyond the lab and into the primary care environment, physicians are able to detect airway obstruction earlier, enabling faster treatment. In addition, EasyOne Air fully satisfies the Global Initiative for Obstructive Lung Disease (GOLD) guidelines, recommending spirometry as one of the primary tools to establish a diagnosis of COPD in patients with a historic cough, difficulty breathing or exposures to risk factors, such as smoking4.

“EasyOne Air is a flexible and reliable tool for healthcare professionals to accurately diagnose lung health. This new model includes ndd’s TrueFlow technology for the most accurate way to diagnose the growing number of patients suffering from COPD and other chronic lung diseases,” said

CEO of ndd Medical Technologies, George Harnoncourt:  “The earlier a physician can diagnose a patient, the faster they can offer treatment. The sooner a patient begins treatment, the better their quality of life.”

EasyOne Air connects (via USB) to a computer for direct printing and downloading while also offering the option of portability through a secure Bluetooth connection. The device offers seamless integration with patients’ electronic medical records through EasyOne Connect, a platform for all EasyOne point-of-care solutions.

Equipped to eliminate the potential for human or environmental error in flow measurement, the EasyOne Air ensures accurate and reliable results with every test. Powered by ndd’s propriety ultrasound flow technology, Ultrasonic TrueFlow™, EasyOne Air anticipates interfering variables, allowing it to function independently of gas composition, pressure, temperature and humidity, ensuring consistent, standardized test results every time.

EasyOne Air received CE marking and FDA 510(k) clearance in January 2017. The device is widely available for purchase through select distributors.


2 American Lung Association
4 Global Initiative for Chronic Obstructive Lung Disease



Trinity Health Names Mark LePage, M.D., as Senior Vice President of Medical Groups and Ambulatory Strategy

Prior to his time at IHA, LePage served as chief medical officer of Marshfield Clinic in Wisconsin

Jody Crane, MD Recognized by Modern Healthcare As One of the 50 Most Influential Clinical Executives

Dr. Crane’s work to streamline operations positioned and prepared TeamHealth and its clinicians to face the COVID-19 pandemic. Under Dr. Crane’s leadership, TeamHealth was able to maintain high levels of clinical quality throughout the rapidly changing COVID environment.

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

Subscribe to Medical Device News Magazine here.

Related Articles